- Hemmati Maslakpak M, Negargar S, Farbod A, et al. Effect of mannitol on postoperative delirium in patients undergoing coronary artery bypass graft: a randomised controlled trial. Open Heart 2024;11:e002743. doi:10.1136/ openhrt-2024-002743
In the double-blind study, 90 adult patients undergoing cardiac surgery with cardiopulmonary bypass were randomized. Different primer solutions were used to prepare the heart-lung machine:
The following endpoints were examined in both groups:
Overall, 32.2% of surgical patients experienced postoperative delirium. However, the incidence differed significantly between the two study groups:
No significant differences were observed between the two groups for the other endpoints. This also applied to the reoperation rate, aortic clamp time, and cardiopulmonary bypass interval, which were also analyzed. Furthermore, no significant adverse effects related to mannitol were observed.
But why does acute confusional syndrome occur after surgery? It is known to be a multifactorial pathogenesis. Various factors are involved, including:
In cardiac surgery, cardiopulmonary bypass and its duration are considered risk factors for the occurrence of postoperative confusion. Rapid changes in temperature, intravascular pH, and arterial blood pressure during cardiopulmonary bypass can trigger a pronounced inflammatory response. This affects cerebral perfusion, oxygen consumption, and oxygen supply to the affected brain area. As a result, hypoxia and ischemia of the brain tissue can occur, which significantly increases the risk of postoperative delirium.
The beneficial effects of using mannitol in the primer solution of the heart-lung machine are based on several mechanisms:
This randomized controlled trial demonstrates a significant reduction in the risk of delirium with mannitol. Due to the limited sample size, larger studies are needed to confirm these results. Neither mortality nor length of intensive care stay were higher in the mannitol arm than in the control group. These results provide initial evidence that mannitol may contribute to delirium prevention. Further studies are needed to evaluate its clinical benefit.